Lymphoma & Plasma Cell Disorders
Conference Coverage
20% with cancer on checkpoint inhibitors get thyroid dysfunction
Researchers report more than double the rate of hypothyroidism and more than triple the rate of hyperthyroidism, compared with rates in published...
News
Maintaining cancer care in the face of COVID-19
Oncologists are moving cancer patients to other hospitals, reevaluating the need for cancer treatments, and embracing telemedicine to protect...
News
Blood test might detect multiple cancer types, study suggests
The test, which uses methylation patterns in plasma cell-free DNA, had specificity and sensitivity approaching those needed for population-based...
Latest News
Cancer care and COVID-19 in Seattle, the first U.S. epicenter
Article
How is oncology adapting to COVID-19?
News
Disruptions in cancer care in the era of COVID-19
News
Psoriasis elevates cancer risk
No increased cancer risk occurred in psoriasis patients treated with biologics or in patients with psoriatic arthritis.
News
Older NHL survivors show worse cognitive decline
Video
Experts break down latest CAR T-cell advances in lymphoma
ORLANDO – An expert panel of physicians discusses the latest research on CAR T-cell therapy in lymphoma, presented at the 2019 annual meeting of...
News
CAR T-cell therapy may worsen mental health in some patients
